Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.46 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | TERT | O14746 | 3/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | BLM | P54132 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | FABP4 | P15090 | 2/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.41 |
| ▸ | PPARG | P37231 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | PPARD | Q03181 | 2/20 | 0.41 |
| ▸ | PPARA | Q07869 | 2/20 | 0.41 |
| ▸ | GMNN | O75496 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4355513 | 1.00 | FAAH (0.46) | FAAHTRPV1TSHRTERTCYP1A2 | |
| SCHEMBL4357213 | 1.00 | FAAH (0.46) | FAAHTRPV1TSHRTERTCYP1A2 | |
| SCHEMBL4352989 | 1.00 | FAAH (0.46) | FAAHTRPV1TSHRTERTCYP1A2 | |
| SCHEMBL4352987 | 1.00 | FAAH (0.46) | FAAHTRPV1TSHRTERTCYP1A2 | |
| SCHEMBL4357215 | 1.00 | FAAH (0.46) | FAAHTRPV1TSHRTERTCYP1A2 | |
| SCHEMBL4354367 | 1.00 | FAAH (0.46) | FAAHTRPV1TSHRTERTCYP1A2 | |
| SCHEMBL8034538 | 1.00 | FAAH (0.46) | FAAHTRPV1TSHRTERTCYP1A2 | |
| SCHEMBL4355514 | 1.00 | FAAH (0.46) | FAAHTRPV1TSHRTERTCYP1A2 | |
| SCHEMBL4354350 | 1.00 | FAAH (0.46) | FAAHTRPV1TSHRTERTCYP1A2 | |
| SCHEMBL4354369 | 1.00 | FAAH (0.46) | FAAHTRPV1TSHRTERTCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111825710-B | Alkoxysilyl group-containing organosilane compound, method for producing same, composition containing same, and cured product | 信越化学工业株式会社 | 2024-08-23 | — | — | CN | disclosed |
| US-11739184-B2 | Polysiloxazane compound having alkoxysilyl group, process for producing same, and composition and cured product including same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-08-29 | — | — | US | disclosed |
| US-11708460-B2 | Alkoxysilyl group-containing organic silazane compound, method for producing same, composition containing same and cured product | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-07-25 | — | — | US | disclosed |
| US-20230192731-A1 | PROCESS FOR THE STEPWISE SYNTHESIS OF SILAHYDROCARBONS | MOMENTIVE PERFORMANCE MATERIALS INC. | 2023-06-22 | — | — | US | disclosed |
| EP-3798252-B1 | POLYSILOXAZANE COMPOUND HAVING ALKOXYSILYL GROUP, PROCESS FOR PRODUCING SAME, AND COMPOSITION AND CURED PRODUCT INCLUDING SAME | SHINETSU CHEMICAL CO (JP) | 2022-06-29 | — | — | EP | disclosed |
| US-20210095079-A1 | POLYSILOXAZANE COMPOUND HAVING ALKOXYSILYL GROUP, PROCESS FOR PRODUCING SAME, AND COMPOSITION AND CURED PRODUCT INCLUDING SAME | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-04-01 | — | — | US | disclosed |
| EP-3798252-A1 | POLYSILOXAZANE COMPOUND HAVING ALKOXYSILYL GROUP, PROCESS FOR PRODUCING SAME, AND COMPOSITION AND CURED PRODUCT INCLUDING SAME | Shin-Etsu Chemical Co., Ltd. (JP) | 2021-03-31 | — | — | EP | disclosed |
| CN-111825710-A | Organosilazane compounds containing alkoxysilyl groups, process for their preparation, compositions containing them and cured products | 信越化学工业株式会社 | 2020-10-27 | — | — | CN | disclosed |
| US-20200332071-A1 | ALKOXYSILYL GROUP-CONTAINING ORGANIC SILAZANE COMPOUND, METHOD FOR PRODUCING SAME, COMPOSITION CONTAINING SAME AND CURED PRODUCT | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-10-22 | — | — | US | disclosed |
| EP-3725822-A1 | ALKOXYSILYL GROUP-CONTAINING ORGANIC SILAZANE COMPOUND, METHOD FOR PRODUCING SAME, COMPOSITION CONTAINING SAME AND CURED PRODUCT | Shin-Etsu Chemical Co., Ltd. (JP) | 2020-10-21 | — | — | EP | disclosed |
| CN-101395212-A | Curable silicone resin composition and cured body thereof | DOW CORNING TORAY CO LTD (JP) | 2009-03-25 | — | — | CN | disclosed |
| EP-2024439-A1 | CURABLE SILICONE RESIN COMPOSITION AND CURED BODY THEREOF | Dow Corning Toray Co., Ltd. (JP) | 2009-02-18 | — | — | EP | disclosed |
| EP-1989253-A1 | CURABLE SILICONE RESIN COMPOSITION AND CURED BODY THEREOF | Dow Corning Toray Co., Ltd. (JP) | 2008-11-12 | — | — | EP | disclosed |
| WO-2007132932-A1 | CURABLE SILICONE RESIN COMPOSITION AND CURED BODY THEREOF | DOW CORNING TORAY CO., LTD. (JP) | 2007-11-22 | — | — | WO | disclosed |
| WO-2007099863-A1 | CURABLE SILICONE RESIN COMPOSITION AND CURED BODY THEREOF | DOW CORNING TORAY CO., LTD. (JP) | 2007-09-07 | — | — | WO | disclosed |
| EP-1125939-B1 | Process for reducing the amount of linear siloxane in a mixture of linear and cyclic siloxanes | DOW CORNING TORAY SILICONE (JP) | 2005-08-10 | — | — | EP | disclosed |
| WO-2004005404-A1 | CURABLE SILICONE RESIN COMPOSITION AND CURED PRODUCT | DOW CORNING TORAY SILICONE CO.,LTD. (JP) | 2004-01-15 | — | — | WO | disclosed |
| US-6448360-B2 | USING BASIC CATALYST | DOW CORNING TORAY SILICONE CO., LTD. (JP) | 2002-09-10 | — | — | US | disclosed |
| EP-1125939-A1 | Process for the production of cyclic siloxane | Dow Corning Toray Silicone Co., Ltd. (JP) | 2001-08-22 | — | — | EP | disclosed |
| US-20010011120-A1 | Process for the production of cyclic siloxane | DOW TORAY CO., LTD. (JP) | 2001-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11708460-B2 | Alkoxysilyl group-containing organic silazane compound, method for producing same, composition containing same and cured product | OR10J3, ALKBH1, ALKBH2 | FAAH 3131/4885TRPV1 462/4885TSHR 4579/4885 |
| US-20200332071-A1 | ALKOXYSILYL GROUP-CONTAINING ORGANIC SILAZANE COMPOUND, METHOD FOR PRODUCING SAME, COMPOSITION CONTAINING SAME AND CURED PRODUCT | OR10J3, ALKBH1, ALKBH2 | FAAH 3131/4885TRPV1 462/4885TSHR 4579/4885 |
| US-20230192731-A1 | PROCESS FOR THE STEPWISE SYNTHESIS OF SILAHYDROCARBONS | CCR4, SALL4, CCR2 | FAAH 4381/4885TRPV1 4700/4885TSHR 4142/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.